Crinetics Pharmaceuticals, Inc. (CRNX)
84.79
+0.10
(+0.12%)
USD |
NASDAQ |
Aug 24, 16:00
84.79
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Total Assets (Quarterly) : 1.322B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.322B |
| March 31, 2026 | 1.401B |
| December 31, 2025 | 1.135B |
| September 30, 2025 | 1.196B |
| June 30, 2025 | 1.290B |
| March 31, 2025 | 1.361B |
| December 31, 2024 | 1.726B |
| September 30, 2024 | 937.37M |
| June 30, 2024 | 935.54M |
| March 31, 2024 | 978.15M |
| December 31, 2023 | 635.35M |
| September 30, 2023 | 641.54M |
| June 30, 2023 | 293.25M |
| March 31, 2023 | 314.01M |
| December 31, 2022 | 352.18M |
| September 30, 2022 | 384.88M |
| June 30, 2022 | 421.73M |
| March 31, 2022 | 333.29M |
| Date | Value |
|---|---|
| December 31, 2021 | 351.02M |
| September 30, 2021 | 209.36M |
| June 30, 2021 | 216.93M |
| March 31, 2021 | 163.55M |
| December 31, 2020 | 183.44M |
| September 30, 2020 | 200.32M |
| June 30, 2020 | 217.12M |
| March 31, 2020 | 123.88M |
| December 31, 2019 | 130.38M |
| September 30, 2019 | 142.51M |
| June 30, 2019 | 155.15M |
| March 31, 2019 | 166.76M |
| December 31, 2018 | 171.42M |
| September 30, 2018 | 176.68M |
| June 30, 2018 | 74.70M |
| March 31, 2018 | 76.33M |
| December 31, 2017 | 15.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 27.42B |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
| Pfizer Inc. | 201.13B |
| Bristol Myers Squibb Co. | 87.63B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 129.92M |
| Shareholders Equity (Quarterly) | 1.192B |
| Debt to Equity Ratio | 0.0396 |
| Current Ratio | 15.57 |
| Net Debt Paydown Yield | 0.02% |